Pharmacokinetic Study for PCA Derivate Formulations
NCT00729729
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DRUG:
PCA
DRUG:
PCA
DRUG:
PCA
Sponsor
Hadassah Medical Organization